The primary objective of the pilot study is to assess the feasibility of a definitive trial to determine the effect of arthroscopic capsuloligamentous repair (Bankart + Remplissage) vs. coracoid transfer (Latarjet procedure) on recurrent dislocation rates and functional outcomes over a 24-month period.
Who can participate
Age range18 Years – 50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Men and women ages 18-50 years;
* Diagnosis of post-traumatic recurrent anterior dislocation. This will require a minimum of 2 episodes of documented dislocations either by radiographic evidence or documented reduction of anterior shoulder dislocation as well as physical examination eliciting unwanted glenohumeral translation with reproduction of symptoms;
* Mild glenoid bone loss as defined on CT by standardized and reproducible best-fit circle technique (\>10% but \<20%);
* Provision of informed consent.
Exclusion Criteria:
* Patients with concomitant injuries (cuff tear);
* Previous shoulder surgery;
* Patients that will likely have problems, in the judgment of the investigators, with maintaining follow-up;
* Epilepsy;
* Patients who are or at risk of being incarcerated;
* Diagnosis of multidirectional instability;
* Cases involving litigation or workplace insurance claims (e.g. WSIB);
* Confirmed connective tissue disorder (Ehlers-Danlos, Marfans) or Beighton hypermobility score \> 6.
* Pregnancy